Biomarkers as a guide for antimicrobial therapy

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 2, 2010, Pages

  Reinhart, Konrad ^a   Hartog, Christiane S ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antibiotic stewardship; Antimicrobial therapy; Biological marker; Infection; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PROCALCITONIN;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DRUG ABUSE; DRUG EXPOSURE; DRUG USE; EMERGENCY CARE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SEPSIS; SURGICAL PATIENT; TRANSCRIPTOMICS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CLINICAL TRIALS AS TOPIC; DRUG UTILIZATION; HUMANS; PROTEIN PRECURSORS; SEPSIS; TREATMENT OUTCOME;

EID: 78650206803     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.11.009     Document Type: Article

References (28)

1. E.H. Ibrahim, G. Sherman, S. Ward, V.J. Fraser, and M.H. Kollef The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
2. J. Garnacho-Montero, J.L. Garcia-Garmendia, A. Barrero-Almodovar, F.J. Jimenez-Jimenez, C. Perez-Paredes, and C. Ortiz-Leyba Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 31 2003 2742 2751
3. J. Valles, J. Rello, A. Ochagavia, J. Garnacho, and M.A. Alcala Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival Chest 123 2003 1615 1624
4. F.M. Brunkhorst, O.K. Eberhard, and R. Brunkhorst Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin Crit Care Med 27 1999 2172 2176
5. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser, M.M. Gencay, P.R. Huber, and M. Tamm Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 2004 600 607
6. M. Christ-Crain, D. Stolz, R. Bingisser, C. Muller, D. Miedinger, and P.R. Huber Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 2006 84 93
7. V. Nobre, S. Harbarth, J.D. Graf, P. Rohner, and J. Pugin Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial Am J Respir Crit Care Med 177 2008 498 505
8. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 1993 515 518
9. D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, and C. Muller Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin guidance with standard therapy Chest 131 2007 9 19
10. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00832039?term= NCT00832039&rank=1 [accessed 18 August 2010].
11. D. Stolz, N. Smyrnios, P. Eggimann, H. Pargger, N. Thakkar, and M. Siegemund Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Eur Respir J 34 2009 1364 1375
12. M. Briel, P. Schuetz, B. Mueller, J. Young, U. Schild, and C. Nusbaumer Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care Arch Intern Med 168 2008 (2000-7; discussion 2007-8)
13. P. Schuetz, M. Christ-Crain, R. Thomann, C. Falconnier, M. Wolbers, and I. Widmer Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA 302 2009 1059 1066
14. K.B. Kristoffersen, O.S. Sogaard, C. Wejse, F.T. Black, T. Greve, and B. Tarp Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-a randomized trial Clin Microbiol Infect 15 2009 481 487
15. M. Hochreiter, T. Kohler, A.M. Schweiger, F.S. Keck, B. Bein, and T. von Spiegel Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial Crit Care 13 2009 R83
16. L. Bouadma, C.E. Luyt, F. Tubach, C. Cracco, A. Alvarez, and C. Schwebel Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Lancet 375 2010 463 474
17. M. Stocker, M. Fontana, S. El Helou, K. Wegscheider, and T.M. Berger Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial Neonatology 97 2010 165 174
18. S. Gibot Procalcitonin in intensive care units: the PRORATA trial Lancet 375 2010 1605 1606
19. W. Tarnow-Mordi, and V. Gebski Procalcitonin in intensive care units: the PRORATA trial Lancet 375 2010 1605
20. L. Bouadma, C.E. Luyt, F. Tubach, J. Chastre, M. Wolff group ftPt Procalcitonin in intensive care units: the PRORATA trial - author reply Lancet 375 2010 1606 1607
21. P. Schuetz, W. Albrich, M. Christ-Crain, J. Chastre, and B. Mueller Procalcitonin for guidance of antibiotic therapy Expert Rev Anti Infect Ther 8 2010 575 587
22. H. Brodska, T. Drabek, K. Malickova, A. Kazda, A. Vitek, and T. Zima Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study Crit Care 13 2009 R37
23. H.J. Dornbusch, V. Strenger, P. Sovinz, H. Lackner, W. Schwinger, and R. Kerbl Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders Support Care Cancer 16 2008 1035 1040
24. V. Matzaraki, K.I. Alexandraki, K. Venetsanou, C. Piperi, P. Myrianthefs, and N. Malamos Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis Clin Biochem 40 2007 336 342
25. A. Holm, S.S. Pedersen, J. Nexoe, N. Obel, L.P. Nielsen, and O. Koldkjaer Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care Br J Gen Pract 57 2007 555 560
26. J.W. Cals, C.C. Butler, R.M. Hopstaken, K. Hood, and G.J. Dinant Effect of point-of-care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster-randomised trial BMJ 338 2009 b1374
27. S.B. Johnson, M. Lissauer, G.V. Bochicchio, R. Moore, A.S. Cross, and T.M. Scalea Gene expression profiles differentiate between sterile SIRS and early sepsis Ann Surg 245 2007 611 621
28. B.M. Tang, A.S. McLean, I.W. Dawes, S.J. Huang, and R.C. Lin Gene-expression profiling of peripheral blood mononuclear cells in sepsis Crit Care Med 37 2009 882 888